samedan logo
 
 
spacer
home > subscribe to EPC
EPC SUBSCRIPTION FORM

European Pharmaceutical Contractor is available free on a controlled basis to strategic decision makers within the pharmaceutical contract market.

Title:
First Name:
Last Name:
Company Name:
Address 1:
Address 2:
Town / City: ZIP / Post Code:
Country: Other:
Tel.: E-mail:

Please answer the following questions:

1. What is your Primary Field of Work/Business/Industry?



Other:

2. What is your Job Title?



Other:
Additional Information:
Please repeat the security code (not case sensitive)*
   
spacer
News and Press Releases

Glycotope GMBH

Berlin, Germany – August 4, 2010 Glycotope GmbH, a leading glycobiology company, has received regulatory approval by German and Italian regulatory authorities for a Phase I study of Glycotope´s next generation antibody CetuGEX (GT-MAB 5.2-GEX) for the treatment of various solid cancers.
More info >>

 
Industry Events

Evolution Summit 2010

27-29 October 2010, Montreux, Switzerland

Amidst attrition challenges and pressures from stakeholders, the laurels are up for grabs for the next leaders in drug development. While the industry is struggling to achieve financial sustainability and operational viability, it is awaiting the leadership of a new bold visionary who will bring fundamental innovation to overhauling the research approaches of the past. When gearing up for the future, pharmaceutical and biopharmaceutical companies continue securing long-lasting lucrative partnerships along their value chains. Incorporating novel development paradigms and improving internal decision-making pave the way to shorter timelines and growing profit margins.
More info >>

.
©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement